From rare to common and back again: 60years of lysosomal dysfunction

Mol Genet Metab. 2016 Feb;117(2):53-65. doi: 10.1016/j.ymgme.2015.08.008. Epub 2015 Aug 18.

Abstract

Sixty years after its discovery, the lysosome is no longer considered as cell's waste bin but as an organelle playing a central role in cell metabolism. Besides its well known association with lysosomal storage disorders (mostly rare and life-threatening diseases), recent data have shown that the lysosome is also a player in some of the most common conditions of our time; and, perhaps even most important, it is not only a target for orphan drugs (rare disease therapeutic approaches) but also a putative target to treat patients suffering from common complex diseases worldwide. Here we review the striking associations linking rare lysosomal storage disorders such as the well-known Gaucher disease, or even the recently discovered, extremely rare Neuronal Ceroid Lipofuscinosis-11 and some of the most frequent, multifaceted and complex disorders of modern society such as cancer, Parkinson's disease and frontotemporal lobar degeneration.

Keywords: Cancer; Frontotemporal lobar degeneration (FTLD); Gaucher disease (GD); Lysosomal storage disorders (LSDs); Neuronal ceroid lipofuscinosis (NCL); Parkinson's disease (PD).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Frontotemporal Lobar Degeneration / etiology
  • Frontotemporal Lobar Degeneration / genetics
  • Frontotemporal Lobar Degeneration / metabolism
  • Humans
  • Lysosomal Storage Diseases / complications*
  • Lysosomal Storage Diseases / drug therapy
  • Lysosomal Storage Diseases / genetics
  • Lysosomes / metabolism
  • Mutation
  • Neoplasms / etiology
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Parkinson Disease / etiology
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism
  • Rare Diseases / complications
  • Rare Diseases / drug therapy
  • Rare Diseases / genetics